| General Information of DME (ID: DME1434) |
| DME Name |
Unclear metabolic mechanism (DME-unclear), Lactobacillus crispatus
|
| Gene Name |
DME-unclear
|
| Lineage |
Species: Lactobacillus crispatus (Click to Show/Hide the Complete Species Lineage)
Kingdom: Bacteria
Phylum: Firmicutes
Class: Bacilli
Order: Lactobacillales
Family: Lactobacillaceae
Genus: Lactobacillus
Species: Lactobacillus crispatus
|
|
Click to Show/Hide the Molecular/Functional Data (Sequence/Structure/Pathway/Function) of This DME
|
| Tissue Distribution |
Primarily distributed in human vagina.
|
|
|
|
|
|
|
| Full List of Drug(s) Metabolized by This DME |
|
Drugs Approved by FDA
|
Click to Show/Hide the Full List of Drugs: 1 Drugs
|
Tenofovir alafenamide |
Drug Info
|
Approved |
Viral hepatitis
|
ICD11: 1E51
|
[1] |
|
|
|
|
|
|
| References |
| 1 |
Vaginal microbiome modulates topical antiretroviral drug pharmacokinetics. JCI Insight. 2018 Jul 12;3(13). pii: 99545.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
